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Percutaneous epidural neuroplasty (PEN) is an eﬀective and safe procedure for herniated lumbar disc (HLD). Although PEN has
an advantage of adhesiolysis, this procedure cannot decompress the protruded disc. Recently, trans-sacral epiduroscopic laser
decompression (SELD) for HLD has been introduced as a promising alternative methodology. +is study evaluated the clinical
eﬃcacy and safety of SELD compared to PEN, as well as the change in protruded disc volume after SELD through pre- and
postoperative magnetic resonance imaging (MRI), in patients with HLD. +irty consecutive patients underwent SELD (SELD
group), and 45 patients underwent PEN (PEN group). +e Visual Analog Scale (VAS) for leg pain; Oswestry Disability Index
(ODI); 12-Item Short-Form Health Survey (SF-12); preoperative and postoperative 4-, 12-, and 24-week Macnab criteria; and
preoperative and 24-week postoperative lumbar spinal MRIs after SELD were obtained.+ere was no signiﬁcant diﬀerence in age,
sex, duration of symptoms, and the distributions of disc level between the two groups (all P> 0.05). Between the SELD and PEN
groups, preoperative VAS, ODI, and SF-12 scores had no signiﬁcant diﬀerences. However, the VAS, ODI, and SF-12 scores
improved signiﬁcantly after the procedures by postoperative week 24 in each group (all P< 0.05). Furthermore, improvements of
VAS, ODI, SF-12, and success rate of Macnab criteria in the SELD group were better than those in the PEN group (all P< 0.05).
+e protruded disc volume after SELD decreased signiﬁcantly (P � 0.034). All clinical and functional outcomes of patients
undergoing SELD and PEN for HLD improved following the procedures. Notably, SELD was superior to PEN regarding the
degree of improvement in clinical and functional outcomes.+erefore, we suggest that SELD can be used as an eﬀective alternative
to PEN to provide improved clinical and functional outcomes in patients with HLD.
1. Introduction
Percutaneous epidural neuroplasty (PEN) is a minimally
invasive therapy for spinal diseases [1–4]. Although it was
originally developed to treat postoperative adhesion, PEN
has also been used for targeted drug delivery, epidural
scarring, and neural decompression [1, 4]. Additionally, the
procedure has shown good clinical outcomes as a herniated
lumbar disc (HLD) treatment when compared to physio-
therapy [3]. To alleviate radicular or lower back pain in
patients with HLD, PEN can ameliorate aberrant adhesion
and deliver drugs to areas with pathology, including the
nerve root and disc [4, 5]. However, a disadvantage of the
PEN procedure is that it cannot decompress the herniated
disc. Percutaneous lumbar laser ablation is an alternative
solution that addresses this problem [6].
+e ﬁrst clinical percutaneous lumbar laser disc de-
compression was reported in Europe by Choy and colleagues
in 1986 [7]. In percutaneous lumbar laser ablation, laser
energy is delivered to the herniated lumbar disc through a
thin optical ﬁber. +e absorption of applied laser energy
vaporizes the water content of the nucleus pulposus and then
changes its protein structure [8, 9]. +e subsequent re-
duction in the nucleus volume results in reduced intradiscal
pressure, which in turn leads to the decompression of
entrapped nerve roots [6].
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Epiduroscopy is also a newminimally invasive technique
for the management of spine-originating diseases. +e
epiduroscopic view is beneﬁcial for the management of
lumbar spine disease because it provides direct visualization
of spinal pathology and can be used simultaneously with
PEN. Similarly, laser decompression with epiduroscopy can
be a more eﬀective method for treating intraspinal pa-
thologies, such as a herniated nucleus pulposus and painful
microscopic adhesions [6].
Trans-sacral epiduroscopic laser decompression (SELD)
is a new technique that has been reported to be eﬀective in
treating lumbar disc herniation [10]. However, the few
studies that have investigated this procedure involving a
sacral hiatus approach have only reported on clinical out-
comes [10–13].+erefore, the goal of this study is to evaluate
the clinical eﬃcacy and safety of SELD compared to PEN, as
well as the change in disc volume after SELD through pre-
and postoperative magnetic resonance imaging (MRI).
2. Materials and Methods
2.1. Study Design and Patients. Approval for the current
study was granted by the Institutional Review Board of our
institute (approval number, 1-2014-0049). A total of 75
patients who signed an informed consent form were in-
cluded in this study between March 2013 and December
2014. All patients had leg pain that was refractory to con-
servative management, such as medication and physio-
therapy, for more than 6 weeks. Each patient also had a
single level HLD that was checked byMRI. Exclusion criteria
were previous spinal invasive procedure or operation, in-
stability, spondylolisthesis, ossiﬁcation of the posterior
longitudinal ligament, and other traumatic injuries, as well
as underlying systemic diseases like rheumatoid arthritis and
systemic lupus erythematosus.
+e choice of surgical procedure was made by the pa-
tients in this open-label study. Among the 75 patients with
HLD, 30 patients decided to undergo SELD, and the other 45
patients decided to undergo PEN for the treatment of HLD.
However, 2 of the 30 patients in the SELD group and 5 of the
45 patients in the PEN group were not included in the last
follow-up period (Figure 1).
2.2. Surgical Procedures
2.2.1. Percutaneous Epidural Neuroplasty (PEN). PEN was
performed under ﬂuoroscopy as a one-day treatment in a
sterile operating room, and blood pressure, pulse rate, and
pulse oximetry were monitored. After the patient was in the
appropriate prone position, the needle insertion area around
the sacral hiatus was injected with 1% lidocaine (Yooyoung,
Seoul, Korea). An RK epidural needle (Epimed In-
ternational, Johnstown, NY, USA) was introduced into the
caudal epidural space under ﬂuoroscopic guidance. When
the position of the needle was conﬁrmed to be in the epidural
space, a lumbar epidurogram was performed using ap-
proximately 5mL of iodinated contrast medium (IOBRIX,
ACCUZEN, Seoul, Korea). Conﬁrmation of ﬁlling defects
was achieved by observing the contrast agent ﬂow. We also
conﬁrmed that there was no intravenous or subarachnoid
space penetration by the needles. If the needle position was
found to be incorrect, the position of the needle was altered
to address the problem. After adequate conﬁrmation with
the epidurogram, a Racz catheter (Epimed International,
Johnstown, NY, USA) was advanced through the RK needle
to the ﬁlling defect area or pathological site as determined by
MRI. Once the needle was in the ﬁnal location in the lateral
or ventral epidural space, adhesiolysis was performed. After
adhesiolysis, a minimum of 3mL of contrast medium was
injected. If there was no subarachnoid, intravascular, or
another extra epidural ﬁlling, and satisfactory ﬁlling was
obtained in the epidural and targeted regions, 6mL of 0.2%
preservative-free ropivacaine (AstraZeneca, Seoul, Korea)
containing 1,500 units of hyaluronidase (Huons, Seoul,
Korea) and 2mL of dexamethasone (Huons, Seoul, Korea)
were injected [2].
2.2.2. Trans-Sacral Epiduroscopic Laser Decompression
(SELD). +e SELD procedure (Figure 2) was performed
with the patient in a prone position, and physiological
parameters were monitored, similar to the PEN procedure.
At the area of the sacral hiatus, 1% lidocaine (Yooyoung,
Seoul, Korea) was administered, and a 1 cm longitudinal
incision was made in the sacral hiatus region. An epidural
needle was used to puncture the sacral hiatus, and a
steerable catheter (Biovision 3.0 epidural catheter; Bio-
vision Technologies, Golden, CO, USA) was inserted into
the epidural space through the introducing needle. A
ﬂexible epiduroscope (NeedleView CH, Lutronics,
Goyang-si, Gyeonggi-do, Korea) was steered using Bio-
vision 3.0 epidural catheter to the location of the lesion as
determined by MRI. Epidural saline solution was used to
irrigate and clear the area visualized on the endoscopic
video screen as well as to cool the ablation site.+rough the
epiduroscope, we could see the herniated disc in addition
to adhesive bands, inﬂammatory tissues, ﬁbrous connec-
tive tissues, and adipose tissue around the dura and nerve
75 patients with HLD
Open-label,
self-determination
f/u loss (n = 2) f/u loss (n = 5)
SELD (n = 30) PEN (n = 45)
Postoperative 24-week
follow-up (n = 28)
Postoperative 24-week
follow-up (n = 40)
Figure 1: Flow chart showing the number of patients undergoing
treatment by SELD and PEN in the current study. HLD� herniated
lumbar disc; SELD� trans-sacral epiduroscopic laser decompression;
PEN� percutaneous epidural neuroplasty; f/u� follow-up;
POD� postoperative duration.
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root. +rough the epiduroscope (NeedleView CH,
Lutronics, Goyang-si, Gyeonggi-do, Korea), we could see
that the disc was reduced by the Nd : YAG (neodymium-
doped yttrium aluminum garnet) laser system (ACCU-
PLASTI, Lutronic, Goyang-si, Gyeonggi-do, Korea). +e
laser system output power range was from 2.5W (0.5 J,
5 Hz) to less than 5W (0.6 J, 8 Hz or 0.5 J, 10 Hz). After
laser ablation, 6mL of 0.2% preservative-free ropivacaine
(AstraZeneca, Seoul, Korea) containing 1,500 units of
hyaluronidase (Huons, Seoul, Korea) and 2mL of dexa-
methasone (Huons, Seoul, Korea) were injected, as was
done for the PEN procedure.
2.3. Data Collection and Statistical Analysis. +e Visual
Analog Scale (VAS) for leg pain, Oswestry Disability Index
(ODI), 12-Item Short-Form Health Survey (SF-12), and
preoperative and postoperative 4-, 12-, and 24-week
Macnab criteria were obtained for all patients. In addition,
preoperative and 24-week postoperative lumbar spine
MRIs were evaluated to identify changes in disc volume
after SELD. Disc volume was calculated by the following
equation: height (mm) × area (mm2). +e height was de-
ﬁned as the maximal diameter of the disc space
(Figure 3(a)). +e area of disc protrusion was obtained by
using a region of interest (ROI) deﬁned with Centricity
PACS software (GE Healthcare, Little Chalfont, BKM,
England), as in Figure 3(b).
VAS, ODI, and SF-12 scores were analyzed by the re-
peated measures analysis of variance (RM-ANOVA) with
Bonferroni correction (P< 0.0125). Success rates of Macnab
criteria were analyzed by the chi-square test. +e change in
protruded disc volume between pre- and postoperative
SELD measurements was analyzed by the Wilcoxon signed-
rank test. All statistical analyses were performed using SPSS
software version 18 (SPSS Inc., Chicago, IL, USA), and
statistical signiﬁcance was deﬁned as P< 0.05.
3. Results
3.1. Demographics. +ere was no signiﬁcant diﬀerence in
age, sex, duration of symptoms, and the distributions of disc
level between the two groups (all P> 0.05; Table 1).
3.2.ClinicalOutcomes. +e results of the repeated measures
analysis of variance (RM-ANOVA) for the changes in the
VAS and ODI and SF-12 scores of the SELD and PEN
groups at the four measurement time points are shown in
Figures 4–6. Between the SELD and PEN groups, the re-
spective preoperative VAS (5.90 ± 2.02 vs 5.07± 1.77,
P � 0.079), ODI (46.07 ± 17.27 vs 38.9± 12.81, P � 0.068),
and SF-12 (31.08± 7.54 vs 29.05± 7.61, P � 0.28) scores
showed no signiﬁcant diﬀerences (Figures 4–6). However,
within each group, the VAS and ODI scores showed a
signiﬁcant decrease, and the SF-12 score showed a
(a) (b)
(c)
Intervertebral
disc
Dorsal
Spinal dura
Laser spot
(d)
Figure 2: SELD procedure. (a) Insertion of SELD catheter through a needle introduced into the sacral hiatus; (b) ﬂuoroscopic epidurogram
at caudal epidural space; (c) placing SELD catheter at disc level L4/5; (d) epiduroscopic view of epidural space. SELD� trans-sacral
epiduroscopic laser decompression; Dorsal� dorsal side of the patient (ventral side of thecal sac); POD� postoperative duration.
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signiﬁcant increase, at postoperative week 24 (all P< 0.05)
for both procedures. Notably, the SELD group showed
better VAS improvement at postoperative week 24 than the
PEN group (1.68± 1.79 vs 3.12± 1.26; P � 0.001; Figure 4).
+e SELD group also showed better ODI improvement at
postoperative week 24 than the PEN group (17.89 ± 14.82 vs
26.5 ± 12.1; P � 0.011; Figure 5). Furthermore, the SF-12
scores of the SELD group were higher than those of the
PEN group at postoperative week 12 (42.07± 8.62 vs
36.27 ± 8.58; P � 0.008) and week 24 (44.30± 7.51 vs
37.22 ± 9.06; P � 0.001) (Figure 6). Finally, the SELD group
showed a signiﬁcantly better success rate as measured by
the Macnab criteria (success deﬁned as “excellent” or
“good” in Macnab criteria) at postoperative weeks 12 and
Table 1: Demographic details of patients segregated into 2 groups
based on the treatment procedure.
SELD
(n� 28)
PEN
(n� 40)
P
value
Age (mean± SD) 44.8± 15.6 50.7± 14.0 0.083
Sex (M : F) 15 :13 15 : 25 0.189
Symptom duration
(months, mean± SD) 6.29± 4.95 7.12± 4.07 0.378
Level (n, %) 0.067
L3/4 1 (3.6) 2 (5)
L4/5 14 (50) 30 (75)
L5/S1 13 (36.4) 8 (20)
SELD� trans-sacral epiduroscopic laser decompression; PEN� percuta-
neous epidural neuroplasty; L� lumbar; S � sacral.
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Figure 5: Comparison of ODI scores for leg pain between the SELD
and PEN groups at preoperative weeks 4, 12, and 24; ∗statistically
signiﬁcant diﬀerences were observed at 24weeks postoperatively
(P � 0.011). ODI � Oswestry Disability Index; SELD� trans-sacral
epiduroscopic laser decompression; PEN� percutaneous epidural
neuroplasty; POD� postoperative duration.
(a) (b)
Figure 3: Protruded disc volume. +e disc volume was calculated by multiplication of the height and the area. (a) +e height (white arrow)
in T2 sagittal MRI; (b) the area (white ellipse).
10
8
6
4
2
0
V
A
S 
fo
r l
eg
 p
ai
n
Preoperative POD 4wk POD 12wk POD 24wk
∗
SELD
PEN
Figure 4: Comparison of VAS scores for leg pain between the SELD
and PEN groups preoperatively and at 4, 12, and 24 weeks after
treatment; ∗statistically signiﬁcant diﬀerences were observed at 24
(P � 0.001) weeks postoperatively. SELD� trans-sacral epiduro-
scopic laser decompression; PEN� percutaneous epidural neuro-
plasty; VAS� visual analog scale; POD� postoperative duration.
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24 (P≤ 0.001, P≤ 0.001, Table 2).+ere were no procedure-
related complications such as nerve damage, dural punc-
ture, increased intracranial pressure, or postoperative in-
fection in either group.
3.3. Disc Volume Changes and Laser Output. In the patients
who underwent the SELD procedure, the average protruded
disc volume was 452.54± 322.08mm3 preoperatively and
361.69± 339.10mm3 at 24weeks postoperatively, which
translated to a signiﬁcant decrease in the volume of
90± 244.25mm3 (90mm3 � 0.09 cc; P � 0.034, Figures 7 and
8). +e total laser output energy during the procedure was
776.25± 609.14W.
4. Discussion
Previous studies have shown that PEN with or without
epiduroscopy demonstrated superior eﬀectiveness com-
pared with both physical therapy and caudal epidural in-
jections [3, 4]. Its advantages extend beyond adhesiolysis to
include drug delivery to areas of pathology that occur in
diseases such as HLD or stenosis [1, 2]. Especially epi-
duroscopic adehisoilysis had good outcome regarding
adhesiolysis even if postlumbar surgery syndrome or failed
back surgery syndrome had severe adhesion [14–16]. Al-
though PEN with or without epiduroscopy can ameliorate
aberrant adhesion and deliver the drugs to target areas such
as the nerve root and lumbar disc, it is not possible to
decompress a herniated disc with this procedure. +erefore,
a new procedure that combines decompression with PEN
through the use of a laser system (SELD) has been developed
for use in treating spinal lumbar diseases [10, 11, 13, 17].+e
main diﬀerence between PEN and SELD is, therefore, the
ability to perform laser ablation of the disc or adhesion
tissue. Accordingly, we compared the eﬃcacy, safety, and
change in protruded disc volume with SELD for the treat-
ment of HLD in patients with radicular pain.
Although VAS, ODI, and SF-12 scores improved sig-
niﬁcantly after each procedure at postoperative week 24 (all
P< 0.05), improvements of VAS, ODI, and SF-12 and the
success rate of Macnab criteria in the SELD group were
better than those in the PEN group (all P< 0.05). As de-
scribed in previous studies, SELD enables vaporization of
the protruded part of the disc, cauterization of the sinu-
vertebral nerve, lysis of adhesions near the nerve root, and
irrigation of inﬂamed areas [10]. Consequently, in our
study, a comparison between pre- and postoperative MRI
images showed that the protruded disc volume decreased
signiﬁcantly by week 24 postoperatively (P � 0.034). Fur-
thermore, we could conﬁrm the decompression of the
nerve root and thecal sac during the SELD procedure.
Laser ablation also enables a contained herniated disc to
be physically changed to an uncontained herniated disc. +is
allows mononuclear cells entering along the margins of the
extruded disc to express inﬂammatory mediators and induce
angiogenesis, causing persistent inﬂammation [18]. An
uncontained herniated disc has a possibility of absorption due
to dehydration and the inﬂammation-mediated resorption
response because the water content of the disc is higher [19].
Komori et al. [20] noted that the more the herniated nucleus
pulposus migrated, the greater the subsequent decrease in
size. Henmi et al. [21] reported that large protruded disc
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Figure 6: Comparison of SF-12 scores for leg pain between the SELD
and PEN groups preoperatively and at 4, 12, and 24 weeks after
treatment; ∗, †statistically signiﬁcant diﬀerences were observed at 12
(P � 0.008) and 24 (P � 0.001) weeks postoperatively. ODI �
Oswestry Disability Index; SELD� trans-sacral epiduroscopic laser
decompression; PEN� percutaneous epidural neuroplasty.
Table 2: Success rate between SELD and PEN groups using
Macnab criteria.
Success rate of Macnab criteria
(n, %)
SELD
(n � 28)
PEN
(n � 40)
P
value
POD 4 weeks 24 (85.7%) 25 (62.5%) 0.054
POD 12weeks 27 (96.4%) 18 (45.0%) ≤0.001
POD 24weeks 27 (96.4%) 20 (50.0%) ≤0.001
Success � excellent and good in Macnab criteria, SELD� trans-sacral
epiduroscopic laser decompression; PEN� percutaneous epidural neuro-
plasty; POD� postoperative duration.
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Figure 7: Change of protruded disc volume from preoperatively to
after the SELD procedure. ∗Statistically signiﬁcant diﬀerences were
observed at 24 weeks postoperatively (P � 0.034). SELD� trans-
sacral epiduroscopic laser decompression; Preop� preoperative
day; POD� postoperative duration.
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fragments diminished more than small fragments. +e au-
thors postulated that it may be due to the larger disc fragments
having more water content [20, 21]. Based on the reasons
discussed above, the results from this study demonstrate that
SELD is the superior option for treating HLD in patients with
radicular pain compared to PEN.
It is important to note that, in our study, SELD was not
always superior to PEN during every follow-up period. At
postoperative weeks 4 and 12, for example, the VAS and
ODI scores showed no signiﬁcant diﬀerences between the
SELD and PEN groups. Rather, the VAS and ODI scores in
the SELD group at postoperative week 4 appeared to be
higher than those in the PEN group, although not sig-
niﬁcantly (P> 0.05). A previous study reported that be-
cause any tissue exposed to the laser is injured
microscopically, there were many necrotic cells in all of the
tissues where the laser was applied in a parallel as well as
perpendicular direction [22]. +is ﬁnding demonstrated
that laser ablation to the disc and adhesion tissue induced
an inﬂammatory reaction. +erefore, it is inferred that, in
our study, pain sustained until postoperative week 4 was
likely due to this inﬂammatory reaction [23]. However,
there was no diﬀerence in SF-12 scores and the success rate
of Macnab criteria between the two groups at postoperative
week 4.
SELD also has certain disadvantages. A longer operation
time is necessary to perform SELD compared with PEN. In
addition, because of the possibility of tissue damage, such as
thermal injury to the nerve root and dura, it is technically
diﬃcult to ablate the protruded disc and perineural adhe-
sions [10, 11, 22]. In this study, there were no complications
during the SELD or PEN procedures.
+ere are some limitations to this study. First, although
we performed a comprehensive prospective case-control
study, it is nonetheless limited compared to a randomized
controlled trial. However, this did not aﬀect the outcome of
the SELD group in any way. Second, more studies with larger
sample sizes and longer follow-up periods are required to
address the relatively small sample size and short-term
problems encountered in this study.
5. Conclusion
To the best of our knowledge, this is the ﬁrst comparative
study to investigate the diﬀerences in outcomes of patients
undergoing SELD and PEN for the treatment of HLD. All
clinical outcomes were improved in both groups. However,
SELD provided a signiﬁcantly greater clinical success rate
than PEN. Furthermore, the volume of protruded lumbar
disc decreased signiﬁcantly after SELD. We suggest that
(a) (b)
(c) (d)
Figure 8: Case presentation regarding change of protruded disc volume after the SELD procedure. +e 38-year-old man suﬀered from right
leg pain with the protruded disc at L5/S1 level. After the SELD procedure, the volume of the protruded disc at the L5/S1 level decreased. (a)
Preoperative sagittal T2 MR image; (b) preoperative axial T2 MR image; (c) postoperative sagittal T2 MR image; (d) postoperative axial T2
image. SELD� trans-sacral epiduroscopic laser decompression; MR�magnetic resonance.
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SELD can be used to achieve better outcomes in patients
with HLD compared to procedures such as PEN that does
not include laser ablation.
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